RELATED NEWS

• Coronavirus: Europe looks for a way out of vaccine fiasco

  Vaccination centers in Europe are standing ready — but no vaccine is available. Pfizer has cut its production, and AstraZeneca has announced it would be delivering 60% less than agreed with the EU.

• COVID-19 Vaccine FAQs

  Since the beginning of the pandemic, little has been met with more anticipation (or hesitancy) than the promise of a COVID-19 vaccine. However, by mid-November 2020, less than a year after SARS-CoV-2 gained global recognition as a public health threat, this “promise” has moved from speculation to possibility, and the news has everyone talking.

• "หมอธีระวัฒน์" เผยงดอาหารแบบ IF ช่วยลดอาการรุนแรงติดโควิด

  วันที่ 12 ส.ค.65 นพ.ธีระวัฒน์ เหมะจุฑา หัวหน้าศูนย์วิทยาศาสตร์สุขภาพโรคอุบัติใหม่ คณะแพทยศาสตร์ โรงพยาบาลจุฬาลงกรณ์ โพสต์ข้อความผ่านเฟซบุ๊ก Thiravat Hemachudha ระบุว่า...

• Latest research: How to prevent coronavirus infections | COVID-19 Special

  How do we get infected with the coronavirus? Japanese researchers have used a supercomputer to simulate how viral particles move. The simulation makes the invisible threat visible and could help people evaluate risk of infection. Their findings show how far even the smallest droplets can spread and demonstrate how masks, social distancing and humidity impact the spread of COVID-19. Their research suggests that the use of humidifiers may help limit infections indoors during times when regular ventilation isn’’t possible.

• New antibody therapies may cut deaths, reduce exposure to COVID-19, data shows

  While the push to get Americans vaccinated continues across the country, preliminary data has emerged that lab-created monoclonal antibodies could be a treatment for COVID-19.